Adrian Lupescu Selected Research

Annexin A5

5/2014	In vitro induction of erythrocyte phosphatidylserine translocation by the natural naphthoquinone shikonin.
1/2014	Stimulation of erythrocyte cell membrane scrambling by gedunin.
9/2013	Triggering of suicidal erythrocyte death by celecoxib.
9/2013	Effect of honokiol on erythrocytes.
5/2013	Stimulation of suicidal erythrocyte death by fumagillin.
2/2013	Withaferin A-stimulated Ca2+ entry, ceramide formation and suicidal death of erythrocytes.
1/2013	Patulin-induced suicidal erythrocyte death.
12/2012	Gossypol-induced suicidal erythrocyte death.
11/2012	Enhanced Ca2+ entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin.
11/2012	Carbon monoxide-sensitive apoptotic death of erythrocytes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian Lupescu Research Topics

Disease

20	Hemolysis 05/2014 - 01/2012
12	Neoplasms (Cancer) 01/2014 - 04/2009
5	Anemia 01/2015 - 02/2007
2	Shock 01/2016 - 01/2015
1	Hypoxia (Hypoxemia) 01/2014
1	Atherosclerosis 02/2013
1	Parkinson Disease (Parkinson's Disease) 10/2012
1	Inflammation (Inflammations) 04/2012
1	Carcinogenesis 04/2012
1	Balkan Nephropathy (Balkan Endemic Nephropathy) 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2012
1	Hypersensitivity (Allergy) 10/2009
1	Anaphylaxis (Anaphylactic Shock) 10/2009
1	Astrocytoma (Pilocytic Astrocytoma) 04/2009
1	Hepatolenticular Degeneration (Wilson's Disease) 02/2007

Drug/Important Bio-Agent (IBA)

20	PhosphatidylserinesIBA 05/2014 - 02/2007
20	Annexin A5IBA 05/2014 - 01/2012
19	Hemoglobins (Hemoglobin)IBA 01/2015 - 01/2012
16	CeramidesIBA 01/2016 - 02/2007
12	AntibodiesIBA 05/2014 - 01/2012
6	Fluo-3IBA 05/2014 - 01/2012
6	LuciferinsIBA 04/2012 - 01/2012
6	LuciferasesIBA 04/2012 - 01/2012
6	Adenosine Triphosphate (ATP)IBA 04/2012 - 01/2012
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2016 - 02/2007
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014 - 01/2014
2	diacetyldichlorofluoresceinIBA 02/2013 - 01/2012
2	AntioxidantsIBA 02/2013 - 01/2012
2	MycotoxinsIBA 01/2013 - 01/2012
1	Vitamin D FDA LinkGeneric 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Sucrose (Saccharose)IBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	geduninIBA 01/2014
1	Novobiocin (Streptonivicin)FDA Link 01/2014
1	cryptotanshinoneIBA 01/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2013
1	Celecoxib (Celebrex)FDA Link 09/2013
1	honokiolIBA 09/2013
1	diphenyl (biphenyl)IBA 09/2013
1	fumagillinIBA 05/2013
1	CyclohexaneIBA 05/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2013
1	Probucol (Lorelco)FDA Link 02/2013
1	withaferin AIBA 02/2013
1	TriterpenesIBA 02/2013
1	PatulinIBA 01/2013
1	GossypolIBA 12/2012
1	Antiviral Agents (Antivirals)IBA 12/2012
1	Male Contraceptive Agents (Male Contraceptives)IBA 12/2012
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2012
1	tricarbonyldichlororuthenium (II) dimerIBA 11/2012
1	RotenoneIBA 10/2012
1	PesticidesIBA 10/2012
1	chromium hexavalent ionIBA 04/2012
1	ApigeninIBA 01/2012
1	polytyrosineIBA 01/2012
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2012
1	Pharmaceutical PreparationsIBA 01/2012
1	Sunitinib (Sutent)FDA Link 01/2012
1	Sorafenib (BAY 43-9006)FDA Link 01/2012
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 01/2012
1	OchratoxinsIBA 01/2012
1	gambogic acidIBA 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	ochratoxin AIBA 01/2012
1	sulindac sulfideIBA 01/2012
1	tanshinoneIBA 01/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2009
1	Ion Channels (Ion Channel)IBA 10/2009
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2009
1	N-Methylaspartate (NMDA)IBA 04/2009
1	AcidsIBA 02/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2012